Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

BulgariaBack to Bulgaria

Clinical trials in Bankya

2 clinical trials in Bankya, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Bankya at a glance
2
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Bankya

Open in trial search

Cardiovascular disorder

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus+2

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Bankya

What the registry says about research in the country

01 Bankya
Cardiovascular and Metabolic Research
Clinical trial activity in Bankya is focused on cardiovascular disease and nutritional and metabolic diseases, with studies looking at ways to improve long-term health outcomes in people at higher risk. Evaluating a potential therapy for reducing the risk of major heart and blood vessel events Studying treatment effects in people with obesity and related metabolic conditions Exploring whether new approaches can better support prevention and disease control This research is aimed at understanding how new treatments may help lower serious cardiovascular risks and improve care for patients with complex metabolic health needs.
Kidney and Metabolic Disease Research
Another key area of study involves chronic kidney disease, including cases with or without type 2 diabetes, where researchers are examining whether new therapies can reduce kidney damage and slow disease progression. Assessing treatment impact on kidney health through changes linked to urinary albumin levels Focusing on patients with chronic kidney disease alongside metabolic risk factors Comparing how different treatment strategies may support better renal outcomes These studies reflect a practical effort to improve diagnosis-related markers and treatment effectiveness in kidney disease management.
Back to BulgariaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.